What is LRCX revenue?

Lam Research Corporation (LRCX) reported $26.13B of revenue for the twelve months ended Sep 27, 2026. That is up 33.4% from the year before. Revenue for fiscal 2026 was $23.23B.

Yes. Lam Research Corporation earned $8.45B in net income for the twelve months ended Sep 27, 2026, a net margin of 32.3%.

How much cash and debt does LRCX have?

Lam Research Corporation reported $7.44B in cash and cash equivalents and $3.73B of debt on its most recent balance sheet in SEC filings.

How fast is LRCX revenue growing?

Lam Research Corporation's revenue changed +26.0% in fiscal 2026, to $23.23B. Its compound annual growth rate was +9.7% over 5 years and +14.7% over 10 years.

What is LRCX gross margin?

Lam Research Corporation's gross profit was $13.34B on $26.13B of revenue for the twelve months ended Sep 27, 2026, a gross margin of 51.1%.

What is LRCX free cash flow?

Lam Research Corporation generated $6.54B of free cash flow for the twelve months ended Sep 27, 2026, which is operating cash flow of $7.58B less capital expenditures.

What is LRCX earnings per share?

Diluted earnings per share were $6.71 for the twelve months ended Sep 27, 2026, from SEC filings, restated for any stock split those filings show.

When did LRCX last report financial results?

The latest statements here come from Lam Research Corporation's 10-Q filed on Oct 22, 2026, covering the period ended Sep 27, 2026.

Financials · LRCX

Lam Research Corporation (LRCX) financials

For the twelve months ended Sep 27, 2026, Lam Research Corporation reported $26.13B of revenue and $8.45B of net income.

Revenue, TTM: $26.13B
Revenue growth, YoY: +33.4%
Net income, TTM: $8.45B
Net income growth, YoY: +45.4%
Net margin: 32.3%
Free cash flow, TTM: $6.54B
EPS, diluted, TTM: $6.71
EPS growth, YoY: +48.1%
Cash: $7.44B
Total debt: $3.73B
P/E: 29.63
P/S: 9.58
Market cap: $250.38B

Annual revenue$23.23B

FY2017FY2026

Annual net income$7.27B

FY2017FY2026

Annual free cash flow$4.89B

FY2017FY2026

LRCX revenue and earnings growth

LRCX revenueQ1 2027$8.22B

Quarter YoY: +54.4%
QoQ: +22.3%
FY YoY: +26.0%
5Y CAGR: +9.7%
10Y CAGR: +14.7%

LRCX revenue was $8.22B in fiscal Q1 2027 (ended Sep 27, 2026), up 54.4% from a year earlier and up 22.3% from the prior quarter. For the full fiscal 2026 it was $23.23B, up 26.0% from fiscal 2025. Compound annual growth was +9.7% over 5 years and +14.7% over 10 years. It rose in 8 of the last 10 fiscal years. Fiscal 2026 is the highest of the 15 fiscal years on file.

LRCX net incomeQ1 2027$2.75B

Quarter YoY: +75.5%
QoQ: +20.9%
FY YoY: +35.6%
5Y CAGR: +13.2%
10Y CAGR: +23.0%

LRCX net income was $2.75B in fiscal Q1 2027 (ended Sep 27, 2026), up 75.5% from a year earlier and up 20.9% from the prior quarter. For the full fiscal 2026 it was $7.27B, up 35.6% from fiscal 2025. Compound annual growth was +13.2% over 5 years and +23.0% over 10 years. It rose in 7 of the last 10 fiscal years. Fiscal 2026 is the highest of the 15 fiscal years on file.

LRCX EPSQ1 2027$2.19

Quarter YoY: +76.6%
QoQ: +21.0%
FY YoY: +38.8%
5Y CAGR: +16.4%
10Y CAGR: +27.1%

LRCX diluted EPS was $2.19 in fiscal Q1 2027 (ended Sep 27, 2026), up 76.6% from a year earlier and up 21.0% from the prior quarter. For the full fiscal 2026 it was $5.76, up 38.8% from fiscal 2025. Compound annual growth was +16.4% over 5 years and +27.1% over 10 years.

LRCX free cash flowQ1 2027$3.24B

Quarter YoY: +103.3%
QoQ: +155.4%
FY YoY: -9.7%
5Y CAGR: +8.6%
10Y CAGR: +15.3%

LRCX free cash flow was $3.24B in fiscal Q1 2027 (ended Sep 27, 2026), up 103.3% from a year earlier and up 155.4% from the prior quarter. For the full fiscal 2026 it was $4.89B, down 9.7% from fiscal 2025. Compound annual growth was +8.6% over 5 years and +15.3% over 10 years. It rose in 6 of the last 10 fiscal years.

Export CSV

Income statement

Income statement
Line item	FY2026 Jun 28, 2026	FY2025 Jun 29, 2025	FY2024 Jun 30, 2024	FY2023 Jun 25, 2023	FY2022 Jun 26, 2022	FY2021 Jun 27, 2021	FY2020 Jun 28, 2020	FY2019 Jun 30, 2019	FY2018 Jun 24, 2018	FY2017 Jun 25, 2017
Revenue	$23.23B	$18.44B	$14.91B	$17.43B	$17.23B	$14.63B	$10.04B	$9.65B	$11.08B	$8.01B
Cost of revenue	$11.51B	$9.46B	$7.85B	$9.65B	$9.36B	$7.82B	$5.44B	$5.30B	$5.91B	$4.41B
Gross profit	$11.73B	$8.98B	$7.05B	$7.78B	$7.87B	$6.81B	$4.61B	$4.36B	$5.17B	$3.60B
Research and development	$2.38B	$2.10B	$1.90B	$1.73B	$1.60B	$1.49B	$1.25B	$1.19B	$1.19B	$1.03B
Selling, general and admin	$1.15B	$981.70M	$868.25M	$832.75M	$885.74M	$829.88M	$682.48M	$702.41M	$762.22M	$667.49M
Operating income	$8.20B	$5.90B	$4.26B	$5.17B	$5.38B	$4.48B	$2.67B	$2.46B	$3.21B	$1.90B
Interest expense	$156.88M	$178.20M	$185.24M	$186.46M	$184.76M	$208.60M	$177.44M	$117.26M	$97.39M	$117.73M
Pre-tax income	$8.26B	$5.96B	$4.36B	$5.11B	$5.19B	$4.37B	$2.57B	$2.45B	$3.15B	$1.81B
Income tax	$997.08M	$599.91M	$532.45M	$598.28M	$587.83M	$462.35M	$323.23M	$255.14M	$771.11M	$113.91M
Net income	$7.27B	$5.36B	$3.83B	$4.51B	$4.61B	$3.91B	$2.25B	$2.19B	$2.38B	$1.70B
EPS, basic	$5.79	$4.17	$2.91	$3.33	$3.29	$2.72	$1.56	$1.44	$1.47	$1.05
EPS, diluted	$5.76	$4.15	$2.90	$3.32	$3.27	$2.69	$1.51	$1.37	$1.32	$0.92
Diluted shares	1.26B	1.29B	1.32B	1.36B	1.41B	1.45B	1.49B	1.60B	1.81B	1.84B

Balance sheet

Balance sheet
Line item	FY2026 Jun 28, 2026	FY2025 Jun 29, 2025	FY2024 Jun 30, 2024	FY2023 Jun 25, 2023	FY2022 Jun 26, 2022	FY2021 Jun 27, 2021	FY2020 Jun 28, 2020	FY2019 Jun 30, 2019	FY2018 Jun 24, 2018	FY2017 Jun 25, 2017
Cash and equivalents	$5.58B	$6.41B	$5.85B	$5.59B	$3.77B	$4.67B	$5.17B	$3.91B	$4.77B	$2.63B
Receivables	$5.34B	$3.38B	$2.52B	$2.82B	$4.31B	$3.03B	$2.10B	$1.46B	$2.18B	$1.67B
Inventory	$4.28B	$4.31B	$4.22B	$4.82B	$3.97B	$2.69B	$1.90B	$1.54B	$1.88B	$1.23B
Current assets	$15.61B	$14.52B	$12.88B	$13.23B	$12.29B	$11.65B	$10.85B	$8.56B	$9.15B	$9.14B
Goodwill	$1.63B	$1.63B	$1.60B	$1.62B	$1.52B	$1.49B	$1.48B	$1.48B	$1.48B	$1.39B
Total assets	$23.53B	$21.35B	$18.74B	$18.78B	$17.20B	$15.89B	$14.56B	$12.00B	$12.48B	$12.12B
Current liabilities	$5.94B	$6.57B	$4.34B	$4.18B	$4.56B	$3.53B	$3.16B	$2.37B	$3.15B	$2.95B
Short-term debt	$147.0K	$749.67M	$501.32M	$421.0K	$0	$0	$836.11M	$667.13M	$610.03M	$908.44M
Long-term debt	$3.73B	$3.72B	$4.47B	$4.96B	$4.96B	$4.99B	$4.96B	$3.77B	$1.76B	$1.78B
Total debt	$3.73B	$4.47B	$4.97B	$4.97B	$4.96B	$4.99B	$5.80B	$4.43B	$2.37B	$2.69B
Total liabilities	$11.06B	$11.48B	$10.21B	$10.57B	$10.92B	$9.86B	$9.38B	$7.28B	$5.90B	$5.14B
Shareholders' equity	$12.47B	$9.86B	$8.54B	$8.21B	$6.28B	$6.03B	$5.17B	$4.67B	$6.50B	$6.82B

Cash flow

Cash flow
Line item	FY2026 Jun 28, 2026	FY2025 Jun 29, 2025	FY2024 Jun 30, 2024	FY2023 Jun 25, 2023	FY2022 Jun 26, 2022	FY2021 Jun 27, 2021	FY2020 Jun 28, 2020	FY2019 Jun 30, 2019	FY2018 Jun 24, 2018	FY2017 Jun 25, 2017
Operating cash flow	$5.86B	$6.17B	$4.65B	$5.18B	$3.10B	$3.59B	$2.13B	$3.18B	$2.66B	$2.03B
Capital expenditures	$966.40M	$759.19M	$396.67M	$501.57M	$546.03M	$349.10M	$203.24M	$303.49M	$273.47M	$157.42M
Free cash flow	$4.89B	$5.41B	$4.26B	$4.68B	$2.55B	$3.24B	$1.92B	$2.87B	$2.38B	$1.87B
Investing cash flow	-$922.15M	-$708.09M	-$370.61M	-$534.56M	$612.27M	$73.27M	-$244.08M	-$1.64B	$2.75B	-$2.05B
Financing cash flow	-$5.72B	-$4.94B	-$4.00B	-$2.83B	-$4.58B	-$4.17B	-$623.93M	-$2.39B	-$3.27B	-$2.63B
Dividends paid	$1.27B	$1.15B	$1.02B	$907.91M	$815.29M	$726.99M	$656.84M	$678.35M	$307.61M	$243.50M
Share repurchases	$3.85B	$3.42B	$2.84B	$2.02B	$3.87B	$2.70B	$1.37B	$3.78B	$2.65B	$811.67M
Stock-based compensation	$386.38M	$343.37M	$293.06M	$286.60M	$259.06M	$220.16M	$189.20M	$187.23M	$172.22M	$149.97M
Depreciation and amortization	$441.53M	$386.28M	$359.70M	$342.43M	$333.74M	$307.15M	$268.52M	$309.28M	$326.39M	$306.90M

Key ratios

Key ratios
Line item	FY2026 Jun 28, 2026	FY2025 Jun 29, 2025	FY2024 Jun 30, 2024	FY2023 Jun 25, 2023	FY2022 Jun 26, 2022	FY2021 Jun 27, 2021	FY2020 Jun 28, 2020	FY2019 Jun 30, 2019	FY2018 Jun 24, 2018	FY2017 Jun 25, 2017
Revenue growth, YoY	26.0%	23.7%	-14.5%	1.2%	17.8%	45.6%	4.1%	-12.9%	38.2%	36.1%
Net income growth, YoY	35.6%	40.0%	-15.1%	-2.0%	17.8%	73.6%	2.8%	-7.9%	40.2%	85.7%
EPS growth, YoY	38.8%	43.1%	-12.7%	1.4%	21.7%	78.1%	10.2%	4.0%	42.5%	77.0%
Gross margin	50.5%	48.7%	47.3%	44.6%	45.7%	46.5%	45.9%	45.1%	46.6%	45.0%
Operating margin	35.3%	32.0%	28.6%	29.7%	31.2%	30.6%	26.6%	25.5%	29.0%	23.7%
Net margin	31.3%	29.1%	25.7%	25.9%	26.7%	26.7%	22.4%	22.7%	21.5%	21.2%
Free cash flow margin	21.1%	29.4%	28.6%	26.8%	14.8%	22.1%	19.1%	29.8%	21.5%	23.4%
Return on equity	58.3%	54.3%	44.8%	54.9%	73.4%	64.8%	43.5%	46.9%	36.6%	24.9%
Return on assets	30.9%	25.1%	20.4%	24.0%	26.8%	24.6%	15.5%	18.3%	19.1%	14.0%
Current ratio	2.63	2.21	2.97	3.16	2.69	3.30	3.43	3.61	2.90	3.10
Debt to equity	0.30	0.45	0.58	0.60	0.79	0.83	1.12	0.95	0.36	0.39

Income statement

Income statement
Line item	Q1 2027 Sep 27, 2026	Q4 2026* Jun 28, 2026	Q3 2026 Mar 29, 2026	Q2 2026 Dec 28, 2025	Q1 2026 Sep 28, 2025	Q4 2025* Jun 29, 2025	Q3 2025 Mar 30, 2025	Q2 2025 Dec 29, 2024	Q1 2025 Sep 29, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 24, 2023
Revenue	$8.22B	$6.72B	$5.84B	$5.34B	$5.32B	$5.17B	$4.72B	$4.38B	$4.17B	$3.87B	$3.79B	$3.76B
Cost of revenue	-	-	-	-	-	$2.58B	$2.41B	$2.30B	$2.17B	$2.03B	$1.99B	$2.00B
Gross profit	$4.30B	$3.48B	$2.91B	$2.65B	$2.68B	$2.59B	$2.31B	$2.07B	$2.00B	$1.84B	$1.80B	$1.76B
Research and development	$666.40M	$642.92M	$583.20M	$573.30M	$576.45M	$580.18M	$525.90M	$494.95M	$495.36M	$497.83M	$512.27M	$469.71M
Selling, general and admin	$348.73M	$322.33M	$280.31M	$267.65M	$279.35M	$268.40M	$226.02M	$244.15M	$243.13M	$216.48M	$215.90M	$228.84M
Operating income	$3.28B	$2.51B	$2.05B	$1.81B	$1.83B	$1.74B	$1.56B	$1.33B	$1.26B	$1.13B	$1.06B	$1.06B
Interest expense	$36.76M	$34.20M	$39.33M	$40.88M	$42.47M	$42.77M	$45.18M	$45.30M	$44.95M	$46.44M	$47.15M	$46.31M
Pre-tax income	$3.31B	$2.56B	$2.01B	$1.84B	$1.86B	$1.78B	$1.54B	$1.35B	$1.29B	$1.15B	$1.09B	$1.09B
Income tax	$559.08M	$277.86M	$186.10M	$242.62M	$290.50M	$58.89M	$206.06M	$157.13M	$177.83M	$134.07M	$127.36M	$132.78M
Net income	$2.75B	$2.28B	$1.83B	$1.59B	$1.57B	$1.72B	$1.33B	$1.19B	$1.12B	$1.02B	$965.83M	$954.27M
EPS, basic	$2.20	$1.82	$1.46	$1.27	$1.24	$1.34	$1.04	$0.93	$0.86	$0.78	$0.74	$0.72
EPS, diluted	$2.19	$1.81	$1.45	$1.26	$1.24	$1.34	$1.03	$0.92	$0.86	$0.78	$0.73	$0.72
Diluted shares	1.26B	-	1.26B	1.26B	1.27B	-	1.29B	1.29B	1.30B	-	1.32B	1.32B

Balance sheet

Balance sheet
Line item	Q1 2027 Sep 27, 2026	Q4 2026* Jun 28, 2026	Q3 2026 Mar 29, 2026	Q2 2026 Dec 28, 2025	Q1 2026 Sep 28, 2025	Q4 2025* Jun 29, 2025	Q3 2025 Mar 30, 2025	Q2 2025 Dec 29, 2024	Q1 2025 Sep 29, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 24, 2023
Cash and equivalents	$7.44B	$5.58B	$4.75B	$6.18B	$6.69B	$6.41B	$5.45B	$5.67B	$6.07B	$5.85B	$5.67B	$5.62B
Receivables	$5.66B	$5.34B	$4.13B	$3.49B	$3.63B	$3.38B	$3.23B	$3.30B	$2.94B	$2.52B	$2.20B	$2.71B
Inventory	$4.55B	$4.28B	$4.00B	$4.04B	$4.10B	$4.31B	$4.46B	$4.36B	$4.21B	$4.22B	$4.32B	$4.43B
Current assets	$18.12B	$15.61B	$13.30B	$14.02B	$14.81B	$14.52B	$13.46B	$13.61B	$13.49B	$12.88B	$12.49B	$13.05B
Goodwill	-	$1.63B	-	-	-	$1.63B	-	-	$1.60B	$1.60B	$1.63B	$1.63B
Total assets	$26.35B	$23.53B	$20.79B	$21.39B	$21.90B	$21.35B	$19.97B	$19.84B	$19.53B	$18.74B	$18.28B	$18.78B
Current liabilities	$7.31B	$5.94B	$5.24B	$6.21B	$6.71B	$6.57B	$5.49B	$5.35B	$5.34B	$4.34B	$4.43B	$4.27B
Short-term debt	-	$147.0K	-	-	-	$749.67M	-	-	-	$501.32M	-	-
Long-term debt	$3.73B	$3.73B	$3.73B	$3.73B	$3.73B	$3.72B	$3.73B	$4.48B	$4.48B	$4.47B	$4.48B	$4.98B
Total debt	$3.73B	$3.73B	$3.73B	$3.73B	$3.73B	$4.47B	$3.73B	$4.48B	$4.48B	$4.97B	$4.48B	$4.98B
Total liabilities	$12.44B	$11.06B	$10.21B	$11.25B	$11.71B	$11.48B	$10.46B	$11.03B	$11.06B	$10.21B	$10.26B	$10.56B
Shareholders' equity	$13.91B	$12.47B	$10.58B	$10.15B	$10.19B	$9.86B	$9.51B	$8.81B	$8.47B	$8.54B	$8.02B	$8.22B

Cash flow

Cash flow
Line item	Q1 2027 Sep 27, 2026	Q4 2026* Jun 28, 2026	Q3 2026 Mar 29, 2026	Q2 2026 Dec 28, 2025	Q1 2026 Sep 28, 2025	Q4 2025* Jun 29, 2025	Q3 2025 Mar 30, 2025	Q2 2025 Dec 29, 2024	Q1 2025 Sep 29, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 24, 2023
Operating cash flow	$3.50B	$1.46B	$1.14B	$1.48B	$1.78B	$2.55B	$1.31B	$741.94M	$1.57B	$862.43M	$1.38B	$1.45B
Capital expenditures	$257.70M	$188.80M	$331.60M	$260.88M	$185.12M	$172.19M	$288.06M	$188.35M	$110.59M	$100.75M	$103.65M	$115.28M
Free cash flow	$3.24B	$1.27B	$809.82M	$1.22B	$1.59B	$2.38B	$1.02B	$553.59M	$1.46B	$761.68M	$1.28B	$1.34B
Investing cash flow	-$266.99M	-$143.74M	-$334.58M	-$257.78M	-$186.05M	-$129.25M	-$292.92M	-$175.38M	-$110.55M	-$101.61M	-$92.36M	-$101.96M
Financing cash flow	-$1.38B	-$480.31M	-$2.23B	-$1.73B	-$1.28B	-$1.51B	-$1.23B	-$935.23M	-$1.26B	-$574.15M	-$1.24B	-$859.89M
Dividends paid	$325.40M	$325.32M	$325.83M	$327.51M	$291.98M	$295.21M	$295.72M	$297.63M	$260.99M	$261.46M	$262.71M	$264.41M
Share repurchases	$1.02B	$246.56M	$1.16B	$1.47B	$975.79M	$1.29B	$435.32M	$697.69M	$997.03M	$373.55M	$980.56M	$645.46M
Stock-based compensation	$114.70M	$103.98M	$96.62M	$88.54M	$97.24M	$94.29M	$87.11M	$81.96M	$80.01M	$79.09M	$76.85M	$69.90M
Depreciation and amortization	$122.07M	$119.64M	$116.32M	$103.92M	$101.64M	$98.44M	$97.34M	$96.20M	$94.30M	$88.36M	$89.92M	$90.94M

Key ratios

Key ratios
Line item	Q1 2027 Sep 27, 2026	Q4 2026* Jun 28, 2026	Q3 2026 Mar 29, 2026	Q2 2026 Dec 28, 2025	Q1 2026 Sep 28, 2025	Q4 2025* Jun 29, 2025	Q3 2025 Mar 30, 2025	Q2 2025 Dec 29, 2024	Q1 2025 Sep 29, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 24, 2023
Revenue growth, YoY	54.4%	30.0%	23.8%	22.1%	27.7%	33.6%	24.4%	16.4%	19.7%	20.7%	-2.0%	-28.8%
Net income growth, YoY	75.5%	32.4%	37.2%	33.8%	40.5%	68.6%	37.8%	24.8%	25.8%	27.1%	18.7%	-35.0%
EPS growth, YoY	76.6%	35.1%	40.8%	37.0%	44.2%	71.8%	41.1%	27.8%	28.4%	30.0%	21.5%	-33.1%
Gross margin	52.3%	51.7%	49.8%	49.6%	50.4%	50.1%	49.0%	47.4%	48.0%	47.5%	47.5%	46.8%
Operating margin	40.0%	37.4%	35.0%	33.9%	34.4%	33.7%	33.1%	30.5%	30.3%	29.1%	27.9%	28.1%
Net margin	33.5%	33.9%	31.2%	29.8%	29.5%	33.3%	28.2%	27.2%	26.8%	26.4%	25.5%	25.4%
Free cash flow margin	39.4%	18.9%	13.9%	22.8%	29.9%	46.1%	21.6%	12.7%	35.0%	19.7%	33.8%	35.6%
Current ratio	2.48	2.63	2.54	2.26	2.21	2.21	2.45	2.54	2.53	2.97	2.82	3.06
Debt to equity	0.27	0.30	0.35	0.37	0.37	0.45	0.39	0.51	0.53	0.58	0.56	0.61

Source: XBRL data Lam Research Corporation files with the SEC, latest filing dated Oct 22, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures and share counts are restated for stock splits the filings show: 10-for-1, first reported Oct 28, 2024.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

LRCX peers

Company	Revenue	Growth	Net income	Net margin	Market cap
LRCX	$26.13B	+33.4%	$8.45B	32.3%	$250.38B
ASMLASML Holding N.V. New York Registry Shares	€32.67B	+15.6%	€9.61B	29.4%	$549.12B
TMOThermo Fisher Scientific Inc	$47.35B	+8.3%	$7.07B	14.9%	$257.42B
DEDeere & Company	$47.98B	+8.0%	$4.87B	10.2%	$181.09B
DHRDanaher Corporation	$25.61B	+5.5%	$4.33B	16.9%	$161.98B
ETNEaton Corporation PLC	$31.98B	+20.1%	$3.90B	12.2%	$132.76B
JCIJohnson Controls International plc	$24.43B	+5.1%	$3.53B	14.5%	$81.79B
ITWIllinois Tool Works Inc.	$16.65B	+4.8%	$3.23B	19.4%	$79.84B
NOCNorthrop Grumman Corporation	$43.59B	+6.5%	$4.52B	10.4%	$74.58B

LRCX FAQ

9 questions

What is LRCX revenue?
Lam Research Corporation (LRCX) reported $26.13B of revenue for the twelve months ended Sep 27, 2026. That is up 33.4% from the year before. Revenue for fiscal 2026 was $23.23B.
Is LRCX profitable?
Yes. Lam Research Corporation earned $8.45B in net income for the twelve months ended Sep 27, 2026, a net margin of 32.3%.
How much cash and debt does LRCX have?
Lam Research Corporation reported $7.44B in cash and cash equivalents and $3.73B of debt on its most recent balance sheet in SEC filings.
How fast is LRCX revenue growing?
Lam Research Corporation's revenue changed +26.0% in fiscal 2026, to $23.23B. Its compound annual growth rate was +9.7% over 5 years and +14.7% over 10 years.
What is LRCX gross margin?
Lam Research Corporation's gross profit was $13.34B on $26.13B of revenue for the twelve months ended Sep 27, 2026, a gross margin of 51.1%.
What is LRCX free cash flow?
Lam Research Corporation generated $6.54B of free cash flow for the twelve months ended Sep 27, 2026, which is operating cash flow of $7.58B less capital expenditures.
What is LRCX earnings per share?
Diluted earnings per share were $6.71 for the twelve months ended Sep 27, 2026, from SEC filings, restated for any stock split those filings show.
When did LRCX last report financial results?
The latest statements here come from Lam Research Corporation's 10-Q filed on Oct 22, 2026, covering the period ended Sep 27, 2026.
Where does this LRCX financial data come from?
Quantisnow builds these statements from the structured XBRL data Lam Research Corporation files with the SEC. It is provided for information only and is not investment advice.